Olympia is a member of the Outsourcing Facilities Association (OFA) trade group that sued the FDA twice over the removal of tirzepatide and then semaglutide (Ozempics active ingredient) from its shortage list
The company has dramatically expanded its market share over the past year, capitalizing on its arch-rival's struggles -- more on that shortly
Future Directions For GLP-1 Receptor Agonists Judging from the current research and development trends, long-acting, oral dosage forms and multi-target receptor agonists are the key directions for the future development of GLP-1 receptor agonists
The questionnaire is detailed enough to give providers the information they need for prescribing decisions, covering areas like cardiovascular health, thyroid function, diabetes status, and family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome, both of which are contraindications for GLP-1 medications
The peptide purity and COA interpretation guide covers the net peptide content verification that prevents the third error
2011;17(12):CR677-CR682